Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCD5 | Q86SK9 | 4/20 | 0.42 |
| ▸ | SCD | O00767 | 2/20 | 0.42 |
| ▸ | ACKR3 | P25106 | 12/20 | 0.40 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.40 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24726438 | 1.00 | SCD5 (0.42) | SCD5SCDACKR3PDE4BPDE4D | |
| SCHEMBL31711345 | 0.93 | SCD5 (0.41) | SCD5SCDMAPTALDH1A1LMNA | |
| SCHEMBL31710894 | 0.93 | ACKR3 (0.41) | SCD5SCDACKR3MAPTALDH1A1 | |
| SCHEMBL31711212 | 0.93 | ACKR3 (0.41) | SCD5SCDACKR3MAPTALDH1A1 | |
| SCHEMBL31711347 | 0.92 | ALDH1A1 (0.43) | SCD5SCDMAPTALDH1A1LMNA | |
| SCHEMBL31711150 | 0.92 | SCD5 (0.41) | SCD5SCDMAPTALDH1A1LMNA | |
| SCHEMBL31711394 | 0.91 | ACKR3 (0.40) | SCD5SCDACKR3PDE4BPDE4D | |
| SCHEMBL31711331 | 0.91 | SCD5 (0.42) | SCD5SCDACKR3 | |
| SCHEMBL31711071 | 0.90 | ALDH1A1 (0.48) | SCD5SCDMAPTALDH1A1LMNA | |
| SCHEMBL31711391 | 0.90 | ACKR3 (0.40) | SCD5SCDACKR3MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4626232-A1 | FUNGICIDAL COMPOSITIONS | Syngenta Crop Protection AG (CH) | 2025-10-08 | — | — | EP | claimed |
| WO-2024115546-A1 | FUNGICIDAL COMPOSITIONS | SYNGENTA CROP PROTECTION AG (CH) | 2024-06-06 | — | — | WO | claimed |
| US-20250325534-A1 | MICROBIOCIDAL TETRAHYDROISOQUINOLINE DERIVATIVES | SYNGENTA CROP PROTECTION AG (CH) | 2025-10-23 | — | — | US | disclosed |
| EP-4626232-A1 | FUNGICIDAL COMPOSITIONS | Syngenta Crop Protection AG (CH) | 2025-10-08 | — | — | EP | disclosed |
| WO-2024115546-A1 | FUNGICIDAL COMPOSITIONS | SYNGENTA CROP PROTECTION AG (CH) | 2024-06-06 | — | — | WO | disclosed |
| EP-4346411-A1 | MICROBIOCIDAL TETRAHYDROISOQUINOLINE DERIVATIVES | Syngenta Crop Protection AG (CH) | 2024-04-10 | — | — | EP | disclosed |
| WO-2022253645-A1 | MICROBIOCIDAL TETRAHYDROISOQUINOLINE DERIVATIVES | SYNGENTA CROP PROTECTION AG (CH) | 2022-12-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250325534-A1 | MICROBIOCIDAL TETRAHYDROISOQUINOLINE DERIVATIVES | IFNG, NOX1, CYP1A1 | SCD5 2304/4885SCD 2597/4885ACKR3 2650/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.